Retatrutide

Research overview

Retatrutide is an investigational peptide designed to activate GLP-1, GIP and glucagon receptors. Clinical research has examined these pathways in relation to appetite regulation, glucose handling, energy expenditure and body-weight change.

Important context

Retatrutide remains an investigational compound and is not approved for general therapeutic use.

Research use only

This product is represented for laboratory and research purposes only. It is not intended for human consumption, diagnosis, treatment or prevention of disease. Speak with a qualified healthcare professional about medical questions.